Depresión y cánceruna revisión orientada a la práctica clínica

  1. Verónica Pousa Rodríguez 1
  2. Ana Miguelez Amboage 1
  3. Manuel Hernández Blázquez 1
  4. Miguel Ángel González Torres 1
  5. Moisés Gaviria 2
  1. 1 Hospital Universitario de Basurto
    info

    Hospital Universitario de Basurto

    Bilbao, España

    ROR https://ror.org/00j4pze04

  2. 2 University of Illinois Department of Psychiatry
Revista:
Revista Colombiana de Cancerología

ISSN: 2346-0199 0123-9015

Año de publicación: 2015

Volumen: 19

Número: 3

Páginas: 166-172

Tipo: Artículo

DOI: 10.1016/J.RCCAN.2015.04.005 DIALNET GOOGLE SCHOLAR lock_openAcceso abierto editor

Otras publicaciones en: Revista Colombiana de Cancerología

Resumen

La depresión es una entidad que afecta a una proporción del 15-25% de los pacientes con cáncer. A pesar de su elevada incidencia, es un trastorno habitualmente infradiagnosticado y que no recibe tratamiento adecuado. Este hecho conduce a una mala calidad de vida, una inadecuada adherencia al tratamiento y una menor tasa de supervivencia en esta población médica. Existe evidencia sobre la eficacia de abordajes tanto farmacológicos como psicoterapéuticos en pacientes oncológicos con depresión. El objetivo de este artículo es aportar una visión sobre aquellas intervenciones con demostrada eficacia que permiten a los pacientes con cáncer desarrollar un mejor afrontamiento de su enfermedad y lograr una mejor calidad de vida.

Referencias bibliográficas

  • Hernández, M,Cruzado, JA,Prado, C,Rodríguez, E,Hernández, C,González, MA. (2012). Salud mental y malestar emocional en pacientes con cáncer. Psicooncología. 9. 233
  • Hernádez, M,Cruzado, JA,Arana, Z. (2007). Problemas psicológicos en pacientes con cáncer: dificultades de detección y derivación al psicooncólogo. Psicooncología. 179
  • United States Center for Disease Control and Prevention. Cancer Incidence and Mortality Data.
  • Gil Moncayo, FL,Costa Requena, G,Javier Pérez, F,Salamero, M,Sánchez, N,Sirgo, A. (2008). Adaptación psicológica y prevalencia de trastornos mentales en pacientes con cáncer. Medicina clínica. 130. 90
  • Kadan-Lottick, NS,Vanderwerker, LC,Block, SD,Zhang, B,Prigerson, HG. (2005). Psyquiatric Disorders and mental health service use in patients with advanced cancer- A report from the coping with cancer study. Cancer. 104. 2872
  • Litofsky, NS,Farace, E,Anderson, F,Meyers, CA,Huang, W,Laws, ER. Depression in patients with high-grade glioma: results of the glioma outcomes project. Neurosurgery. 2004. 358
  • Arnold, SD,Forman, LM,Brigidi, BD,Carter, KE,Schweitzer, HA,Quinn, HE. (2008). Evaluation and characterization of generalized anxiety and depression in patients with primary brain tumors. Neuro Oncol. 10. 171
  • Fras, I,Litin, EM,Pearson, JS. (1967). Comparison of psychiatricsymptoms in carcinoma of the pancreas with those in some other intra-abdominal neoplasm. Am J Psychiatry. 123. 1553
  • Hopwood, P,Stephens, RJ. (2000). Depression in patients with lung cancer: prevalence and risk factors derived from quality-of-life data. J Clin Oncol. 18. 893-903
  • Kissane, DW,Grabsch, B,Love, A,Clarke, DM,Bloch, S,Smith, GC. (2004). Psychiatric disorder in woman with early stage and advanced breast cancer: a comparative analysis. Aust N Z J Psychiatry. 143. 447
  • Evans, DL,McCartney, CF,Nemeroff, CB,Raft, D,Quade, D,Golden, RN. (1986). Depression in woman treated for gynecological cancer: clinical and neuroendocrine assessment. Am J Psychiatry. 143. 447
  • Haeffel, DJ,Getchell, M,Koposov, RA,Yrigollen, CM,Deyoung, CG,Klinteberg, BA. (2008). Association between polymorphisms in the dopamine transporter gene and depression: evidence for a gene-environment interaction in a sample of juvenile detainees. Psychol Sci. 19. 62
  • Sheline, YI,Gado, MH,Kraemer, HC. (2003). Untreated depression and hippocampal volume loss. Am J Psychiatry. 160. 1516
  • Drevets, WC,Savitz, J,Trimble, M. (2008). The subgenual anterior cingu-lated cortex in mood disorders. CNSSpectr. 13. 663
  • Sen, S,Duman, R,Sanacora, G. (2008). Serum BDNF, depression and anti-depressant medications: meta-analyses and implications. Biol Psychiatry. 64. 527
  • Kent, S,Bluthe, RM,Kelley, KW,Dantzer, R. (1992). Sickness behaviour as a new target for drug development. Trends Pharmacol Sci. 13. 24
  • Plotkin, SR,Banks, WA,Kastin, AJ. (1996). Comparison of saturable transport and extracellular pathways in the passage of interleukin-1 alpha across the blood-brain barrier. J Neuroim-munol. 67. 41
  • Rivest, S,Lacroix, S,Vallieres, L,Nadeau, S,Zhang, J,Laflamme, N. (2000). How the blood talks to the brain parenchyma and the paraventricular nucleus of the hypothalamus during systemic inflammatory and infectious stimuli. Proc Soc Exp Biol Med. 223. 22-38
  • Berard, RM,Boermeester, F,Viljoen, G. (1998). Depressive disorders in a out-patient oncology setting: prevalence assessment and management. Psychooncology. 7. 112
  • Kissane, DW,Maj, M,Sartorius, N. (2011). Depression and cancer. John Wiley & Sons.
  • Papanicolaou, DA. (2000). Euthyroid sick syndrome and the role of cytokines. Rev Endocrinol Metab Dis. 1. 43
  • Pelletier, G,Verhoef, MJ,Khatrei, N,Hagan, N. (2002). Quality of life in brain tumor patients: the relative contributions of depression, fatigue, emotional distress, and existential issues. J Neurooncol. 57. 41
  • Musselman, DL,Lawson, DD,Gumnick, JF,Manatunga, AK,Penna, S,Goodkin, RS. (2001). Paroxetine for the prevention of depression induced by high-dose interferon alpha. N Engl J Med. 344. 961
  • DiMatteo, MR,Lepper, HS,Croghan, TW. (2000). Depression is a risk factor for non-compliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Int Med. 160. 2102
  • Jr, Loberiza FR,Rizzo, JD,Bredeson, CN,Antin, JH,Horowitz, MM,Weeks, JC. (2002). Association of depressive syndrome and early deaths among patients after stem-cel transplantation for malignant diseases. J Clin Oncol. 20. 2118
  • Yirmiya, R,Weidenfeld, J,Pollak, Y,Morag, M,Morag, A,Avitsur, R. (1999). Cytokines, ''depression due to a general medical condition'', and antidepressant drugs. Adv Exp Med Biol. 461. 283-316
  • Pelletier, G,Verhoef, MJ,Khatri, N,Hagen, N. (2002). Quality of life in brain tumor patients: the relative contributions of depression, fatigue, emotional distress, and existential issues. J Neuroon-col. 57. 41
  • Lloyd-Williams, M,Shiels, C,Taylor, F,Dennis, M. (2009). Depression --- An independent predictor of early death in patients with advanced cancer. J Affect Disord. 113. 127
  • Passik, SD,Dugan, W,McDonald, MV,Rosenfeld, B,Theobald, DE,Edgerton, S. (1998). Oncologists' recognition of depression in their patients with cancer. J Clin Oncol. 1594-60016
  • Sôllner, W,DeVries, A,Steixner, E,Lukas PSprinzl, G,Rumpold, G. (2001). How successful are oncologists in identifying patient distress, percieved social support, and need for psychosocial counselling?. Br J Cancer. 84. 179
  • Fallowfield, L,Ratcliffe, D,Jenkins, V,Saul, J. (2001). Psychiatric morbidity and its recognition by doctors in patients with cancer. Br J Cancer. 84. 1011
  • Weinberger, MI,Roth, AJ,Nelson, CJ. (2009). Untangling the complexities of depression diagnosis in older cancer patients. Oncologist. 14. 60
  • Vodermaier, A,Linden, W,Siu, C. (2009). Screening for emotional distress in cancer patients: a systematic review of assessment instruments. J Natl Cancer Inst. 101. 1464
  • Hernández Blázquez, M. Estudio longitudinal del malestar emocional y los trastornos psicopatológicos en pacientes de cáncer que reciben tratamiento de radioterapia.
  • Miguel, C,Albuquerque, E. (2011). Drug Interaction in Psychooncology: antidepressants and antineoplastics. Pharmacology. 88. 333
  • Stahl, B,Goldstein, E. (2011). Mindfulness para reducir el estrés: una guía práctica. Editorial Kairós. Barcelona.
  • Rodríguez Vega, B,Bayón Pérez, C. (2013). Comunicación personal: Integrando mindfulness y psicoterapia. Fundación OMIEServicio de Psiquiatría del Hospital de Basurto. Bilbao.
  • Hofmann, S,Sawyer, A,Witt, A,Oh, D. (2010). The effect of mindfulness-based therapy on anxiety and depression: A meta-analytic review. J consult clin psychol. 78. 169
  • Redondo, R. (2008). Zen, la experiencia del asombro. Fabrikart: arte, tecnología industria, sociedad. 8. 212
  • Shennan, C,Payne, S,Fenlon, D. (2011). What is the evidence for the use for mindfulness-based interventions in cancer care?. Psychooncology. 20. 681
  • Rodríguez, B,Priede, A,Maeso, A,Arranz, H,Palao, A. (2011). Cambios psicológicos e intervenciones basadas en mindfulness para los supervivientes de un cáncer. Psicooncología. 8. 7-20
  • Watson, M,Kissane, DW. (2011). Handbook of psychotherapy in cancer care. Wiley-Blackwell. Chichester^eUKWest Sussex UK.
  • Birnie, K,Garland, S,Carlson, L. (2010). Psychological benefits for cancer patients and their partners participating in mindfulness-based stress reduction (MBSR). Psychooncology. 19. 1004
  • Valiente, M. (2006). El uso de la visualización en el tratamiento psicológico de enfermos de cáncer. Psicooncología. 3. 19-34
  • Walker, LG,Anderson, J. (1999). Testing complementary and alternative medicine within a research protocol. Eur J Cancer. 35. 1614
  • Cheung, YL,Molasiotiss, A,Chang, AM. (2003). The effect of progressive muscle relaxation training on anxiety and quality of life after stoma surgery in colorectal cancer patients. Psychooncology. 12. 254
  • Dimeo, FC,Thomas FRabe-Menssen, C,Prõpper FMathias, M. (2004). Effect of aerobic exercise and relaxation training on fatigue and physical performance of cancer patients after surgery. A randomized controlled trial. Supportive Care Cancer. 12. 774
  • Baider, L,Peretz, T,Hadani, PE,Koch, U. (2001). Psychological intervention in cancer patients: a randomized study. Gen Hosp Psychiatry. 23. 272
  • Luebbert, K,Dahme, B,Hasenbring, M. (2001). The effectiveness of relaxation training in reducing treatment-related symptoms and improving emotional adjustment in acute non-surgical cancer treatment: a meta-analytical review. Psychooncology. 10. 490-502
  • Miller, J,Hopkinson, C. (2008). A retrospective audit exploring the use of relaxation as an intervention in oncology and palliative care. Eur J Cancer Care. 17. 488